Updated: Jan 7, 2020
Dr. Amel Karaa is an Assistant Professor and Director of the Mitochondrial Disease Program at the Massachusetts General Hospital in Boston (The Mito Clinic). She received an International Baccalaureate in biology and chemistry (magna cum laude) from the Franzoesiches Gymnasium in Berlin and a medical degree (summa cum laude) from the Universite de Medicine et Pharmacie de Tunis in Tunisia. She has also completed her internal medicine residency and clinical genetic and metabolism fellowship through the genetics program at Harvard University and is board-certified as an internist and clinical geneticist.
Dr. Karaa was the recipient of a 2013 Fellowship and is currently overseeing clinical care for pediatric and adult Mitochondrial Disease patients and conducting clinical research and clinical trials for Mitochondrial Disease. She was elected president of the Mitochondrial Medicine Society in June of 2018 and sits on numerous scientific and medical boards.
Dr. Karaa is also a founder and a board member of the Mitochondrial Care Network (MCN), a US-wide network developing expert centers for Mitochondrial Medicine and a site investigator for the North American Mitochondrial Disease Consortium (NAMDC). She is committed to be an advocate for her Mitochondrial Disease patients and their families, to educate health care providers in recognizing and treating Mitochondrial patients within the community and to be a catalyst for bringing a much needed cure to this population of patients.